A Look At OSI Systems (OSIS) Valuation After Record Q3 Results Backlog Strength And New Radar Contract
OSI Systems, Inc. OSIS | 0.00 |
OSI Systems (OSIS) is on investors’ radar after record fiscal Q3 results, a reported backlog of about US$1.9b, reaffirmed full year guidance, and a new homeland defense radar contract worth up to US$235 million.
The latest record Q3 results, guidance reaffirmation, and the new homeland defense radar contract appear to sit behind a 10.5% 3 month share price return and a stronger 1 year total shareholder return of 28.25%. This suggests momentum has been building over time from a relatively solid multi year base.
If this mix of security, healthcare, and electronics exposure has your attention, it could be worth seeing what else is out there with 34 robotics and automation stocks
With the stock up strongly over 1 and 3 years, a record US$1.9b backlog, and a radar contract worth up to US$235 million already in hand, the key question is whether OSI Systems is still mispriced or if the market is already paying up for its future growth.
Most Popular Narrative: 7.7% Undervalued
At a last close of $282.87 versus a narrative fair value of $306.43, OSI Systems is framed as modestly undervalued, with that view grounded in detailed assumptions about growth, margins, and contract visibility.
Record backlog levels, global customer diversification beyond large legacy contracts like Mexico, and increased investment in R&D for differentiated platforms are cited as factors that could influence OSI’s earnings and free cash flow, and its ability to participate in long-term secular trends related to security and diagnostic infrastructure spending.
Curious what has to happen in security orders, service revenue mix, and profit margins for that fair value to be supported? The most followed narrative outlines specific revenue paths, margin targets, and valuation multiples that would need to align for OSI Systems to reach those modeled outcomes.
Result: Fair Value of $306.43 (UNDERVALUED)
However, this depends on government security orders arriving as expected and on the healthcare division avoiding a prolonged period of weak margins that drags on overall earnings.
Another Angle on Valuation
The narrative fair value points to a 7.7% undervaluation, but our DCF model tells a different story, with an estimate of $263.53 versus the current $282.87, which screens as overvalued. When two methods disagree like this, which one do you trust more for your own thesis?
Next Steps
With mixed signals on valuation and a blend of risks and rewards in play, now is the time to look through the details and decide where you stand. Start with 2 key rewards and 1 important warning sign.
Looking for more investment ideas?
Do not stop your research with a single stock. Widen your view and use screeners to spot opportunities you might otherwise miss.
- Target potential bargains by scanning companies that screen as attractively priced with 48 high quality undervalued stocks.
- Prioritise resilience by focusing on businesses that show solid financial footing through the solid balance sheet and fundamentals stocks screener (44 results).
- Hunt for underfollowed opportunities by checking the screener containing 25 high quality undiscovered gems before they are widely watched.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
